Keywords: Goserelin; Leuprorelin; Prostate cancer; Prostate-specific antigen;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Cytostatic agents; Emerging contaminants; Environmental samples; Liquid chromatography; Gas chromatography; 5-FU; 5-Fluorouracil; ACT-D; actinomycin-D; A-GLU; Aminoglutethimide; APCI; atmospheric pressure chemical ionization; APPI; atmospheric pressure ph
Impact of the Cu(II) ions on the chemical and biological properties of goserelin - coordination pattern, DNA degradation, oxidative reactivity and in vitro cytotoxicity
Keywords: A549; human lung adenocarcinoma cell line; cAMP; cyclic adenosine monophosphate; CT26; mouse colon carcinoma cell line; DFT; Density Functional Theory; DMEM; Dulbecco's Modified Eagle Medium; FBS; fetal bovine serum; FDA; fluorescein diacetate; Gos; goser
Acylation of arginine in goserelin-loaded PLGA microspheres
Keywords: Acylation; Arginine; LC–MSn; PLGA; Peptides; Controlled release; Goserelin
Goserelin plus tamoxifen compared to chemotherapy followed by tamoxifen in premenopausal patients with early stage-, lymph node-negative breast cancer of luminal A subtype
Keywords: Breast cancer; Chemotherapy; Goserelin; GnRH; Tamoxifen;
Goserelin, as an ovarian protector during (neo)adjuvant breast cancer chemotherapy, prevents long term altered bone turnover
Keywords: Bone turnover markers; Primary ovarian insufficiency; Chemotherapy; Breast cancer; Goserelin
An LC–MS/MS method for the simultaneous determination of goserelin and testosterone in rat plasma for pharmacokinetic and pharmacodynamic studies
Keywords: Goserelin; Testosterone; LC–MS/MS; Surrogate analyte; Pharmacokinetic; Pharmacodynamic
Disease Control Outcomes from Analysis of Pooled Individual Patient Data from Five Comparative Randomised Clinical Trials of Degarelix Versus Luteinising Hormone-releasing Hormone Agonists
Keywords: Androgen deprivation therapy; Degarelix; Goserelin; Leuprolide; Prostate cancer;
Goserelin fosters bone elongation but does not prevent ovarian damage in cyclophosphamide-treated prepubertal mice
Keywords: Cyclophosphamide; GnRH-analogues; goserelin; mice; prepubertal; ovary development;
Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancer
Keywords: Endocrine therapy; Fulvestrant; Goserelin; Metastatic breast cancer; Premenopausal patients;
Efficacy of a Second Line Luteinizing Hormone-Releasing Hormone Agonist After Advanced Prostate Cancer Biochemical Recurrence
Keywords: prostate; prostatic neoplasms; prostate-specific antigen; leuprolide; goserelin; ADT; androgen deprivation therapy; CRPC; castrate resistant PC; GA; goserelin acetate; LA; leuprolide acetate; LHRH; luteinizing hormone-releasing hormone; PC; prostate cance
Introducing Vantas: The First Once-Yearly Luteinising Hormone-Releasing Hormone Agonist
Keywords: Buserelin; Goserelin; Histrelin; Implant; Leuprolide; Metastatic prostate cancer; Triptorelin; Vantas
Fertility preservation in women with breast cancer undergoing adjuvant chemotherapy: a systematic review
Keywords: Breast neoplasms; disease-free survival; drug therapy; fertility; gonadotropin-releasing hormone; goserelin; prognosis; survival analysis; tamoxifen
Randomized Comparison of Goserelin Versus Suction Curettage Prior to Thermachoice II Balloon Endometrial Ablation: One-year Results
Keywords: Menorrhagia; endometrial ablation; endometrial thinning; goserelin; thermal balloon endometrial ablation; ThermaChoice II;
Suppression of ovarian function in combination with an aromatase inhibitor as treatment for advanced breast cancer in pre-menopausal women
Keywords: Ovarian function suppression; LHRH agonist; Goserelin; Aromatase inhibitors; Anastrozole; Exemestane; Advanced breast cancer; Pre-menopausal;
Development and validation of a liquid chromatography–tandem mass spectrometry method for the determination of goserelin in rabbit plasma
Keywords: Goserelin; Peptide; Liquid chromatography–tandem mass spectrometry; Rabbit plasma; Pharmacokinetic study
Short term results from GHRH analogue use in pre-menopausal breast cancer in Korea
Keywords: Chemotherapy; Tamoxifen; Gonadotropin-releasing hormone analogue; Goserelin; Leuprorelin
Goserelin versus leuprolide before hysterectomy for uterine fibroids
Keywords: Fibroids; Goserelin; Gonadotropin releasing hormone agonist; Hysterectomy leuprolide
A randomised trial of goserelin versus control after adjuvant, risk-adapted chemotherapy in premenopausal patients with primary breast cancer – GABG-IV B-93
Keywords: Breast cancer; Node-negative; Hormone receptor negative; Premenopausal; Ovarian ablation; GnRH; Goserelin
Administration of goserelin acetate after uterine artery embolization does not change the reduction rate and volume of uterine myomas
Keywords: Goserelin; uterine artery embolization; uterine fibroids; myomas; leiomyomas
Efecto de tibolona en el mioma uterino en pacientes tratadas con análogos de la hormona liberadora de gonadotropinas
Keywords: Mioma uterino; Goserelina; Terapia add-back; Tibolona; Leiomyoma; Goserelin; Hormone replacement therapy; Tibolone;
CMF versus goserelin as adjuvant therapy for node-negative, hormone-receptor-positive breast cancer in premenopausal patients: A randomised trial (GABG trial IV-A-93)
Keywords: Breast cancer; Node-negative; Premenopausal; Ovarian ablation; GnRH; Goserelin; CMF; Chemotherapy
Adjuvant goserelin in pre-menopausal patients with early breast cancer: Results from the ZIPP study
Keywords: Ovarian ablation; Goserelin; Adjuvant; Chemotherapy; Early breast cancer; Pre-menopausal
PARENTERAL MEDROXYPROGESTERONE FOR THE MANAGEMENT OF LUTEINIZING HORMONE RELEASING HORMONE INDUCED HOT FLASHES IN MEN WITH ADVANCED PROSTATE CANCER
Keywords: prostatic neoplasms; goserelin; hot flashes; medroxyprogesterone 17-acetate;
Injection systems for two luteinising hormone-releasing hormone agonists: A comparative assessment of administration times and nurses' perceptions
Keywords: Goserelin; Leuprorelin; LHRH agonists; Prostate cancer; Injection system;